ILT-3/LILRB4 Rekombinanter Antikörper

ILT-3/LILRB4 Rekombinant Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, ELISA

Konjugation

Unkonjugiert

CloneNo.

250356F3

Kat-Nr. : 86142-1-RR

Synonyme

LILRB4, B4, CD85 antigen-like family member K, CD85k, ILT3

---

• 

  WB analysis of A549 using 86142-1-RR

  A549 cells were subjected to SDS PAGE followed by western blot with 86142-1-RR (ILT-3/LILRB4 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse lung using 86142-1-RR

  mouse lung tissue were subjected to SDS PAGE followed by western blot with 86142-1-RR (ILT-3/LILRB4 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: A549-Zellen, Mauslungengewebe

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:2000-1:10000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

86142-1-RR bindet in WB, ELISA ILT-3/LILRB4 und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Rekombinant
• Typ: Antikörper
• Immunogen: ILT-3/LILRB4 fusion protein Eg1743
• Vollständiger Name: leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
• Berechnetes Molekulargewicht: 49kDa
• Beobachtetes Molekulargewicht: 49 kDa
• GenBank-Zugangsnummer: AAH26309.1
• Gene symbol: LILRB4
• Gene ID (NCBI): 11006
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

LILRB4 is an inhibitory receptor in the LILR family mainly expressed on normal and malignant human cells of myeloid origin. LILRB4 is activated and subsequently recruits adaptors to cytoplasmic immunoreceptor tyrosine inhibitory motifs to initiate different signaling cascades, thus playing an important role in physiological and pathological conditions, including autoimmune diseases, microbial infections, and cancers.